Donate

A living WHO guideline on drugs for COVID-19

This living guideline responds to emerging evidence from randomised controlled trials (RCTs) on existing and new drug treatments for covid-19. More than 2800 trials on covid-19 interventions have been registered or are ongoing. Among these are large national and international platform trials (such as RECOVERY, WHO SOLIDARITY, and DISCOVERY) that recruit large numbers of patients, with a pragmatic and adaptive design. These platform trials are currently investigating and reporting on drugs such as antiviral monoclonal antibodies and immunomodulators. This rapidly evolving evidence landscape requires trustworthy interpretation and expeditious clinical practice guidelines to inform clinicians, patients, governments, ministries, and health administrators.
Emergency Medicine Kenya Foundation

Join Our Newsletter

Please complete this form to create an account, receive email updates and much more.
Contact Email *
First Name *
Last Name *
Facility or Organisation *
Designation or Occupation *
County or City *
Country *
Mobile number 
*
*Required Fields
I agree to the Privacy Policy and Terms of Use. It is our responsibility to protect your privacy and we guarantee that your data will be completely confidential.
Strengthening emergency healthcare systems in Kenya to save lives.